Recommendations for Home-Generated Pharmaceutical Collection Programs in California.

Slides:



Advertisements
Similar presentations
Part III: Education and Empowerment UAEM Annual Conference 2012.
Advertisements

429 pharmaceutical care Plan Refa’a AlAjmi. Goal of therpay A goal of therapy is the desired response or endpoint that you and your patient want to achieve.
California Department of Public Health Loriann De Martini, Pharm.D. Chief Pharmaceutical Consultant Center for Healthcare Quality Medication Error Reduction.
Sharps Usage in CA 40 Million People in CA 7.6% are Diabetic 16% Inject Insulin 486,000 People Self-Inject Insulin in CA 2 Syringes Used Per Day/Person.
Highlights and Lessons Learned from the 2006 SF Bay Area’s Safe Medicine Disposal Days sponsored by the Bay Area Pollution Prevention Group Karin D. North.
State of the Region Overview of APR Data for the Western Region Western Regional Resource Center APR Clinic 2010 November 1-3, 2010 San Francisco, California.
JUDGES MEETING 1. Judges Meeting The Judges Meeting –Each Team will be assigned a date and time. Each Senior Examiner will be expected to present their.
The Dilemma of Waste Pharmaceuticals Ann Pistell Maine Department of Environmental Protection (207)
Secure and Responsible Drug Disposal Act of 2010 Takes Effect 10/9/2014 DEA’s goal in implementing the Act is to expand the options available to safely.
The Impact of Canadian Floriculture Imports on the U.S. Floriculture Industry Bruce W. Smith Center for Regional Development Department of Geography Bowling.
PaintCare Paint Stewardship Program Alison Keane, VP, Government Affairs, ACA General Counsel, PaintCare.
Cross-Border Internet Pharmacy: Why are they so dangerous? Louise Binder, Chair Canadian Treatment Action Council.
March, What does the new law require?  20% State student growth data (increases to 25% upon implementation of value0added growth model)  20%
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
La Crosse County Medication Collection Program Jeff Gloyd Special Waste Manager La Crosse County Hazardous Materials Program.
SM SOUTHERN CALIFORNIA EDISON® Page 1 Discussion on CEC’s and SCE’s Forecast Differences Presentation at CEC Preliminary Demand Forecast Workshop July.
Pharmaceutical Waste Take Back in Wisconsin Steve Brachman Waste Reduction Specialist UW-Extension Solid & Hazardous Waste Education Center.
A Report On The Great Work Of The Faculty Salary Administration Review Group March 11, 2015.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
San Francisco’s Safe Medicine Disposal Pilot Program June One Year Update.
© University of California San Francisco Medical School Criteria for Excellence in Faculty Development David M. Irby, PhD Patricia O’Sullivan, EdD Yvonne.
Pitfalls and Lessons Learned: Advanced Implementation Strategies for a Compliant Grant Process National CME Audioconference December 9, 2008.
PHARMACEUTICAL TAKE-BACK PROGRAM MODELS International programs U.S. programs Program attributes Public need Essential program elements.
Margaret Martin Gardiner Assessment Librarian The University of Western Ontario LibQUAL+2007 Canada 25 October 2007.
Tara Vagen October 23, 2008 Highline Community College.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
SURVEYING CUSTOMERS AT YOUR SITES Northwest Hazardous Materials Conference June 25, 2013 Julie D. Mitchell Local Hazardous Waste Management Program King.
EPA’s DRAFT SIP and MODELING GUIDANCE Ian Cohen EPA Region 1 December 8, 2011.
PRESENTATION FOR SENIOR EXECUTIVES Developing empathy.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
Welcome 2011 California Statewide Medical and Health Exercise.
Dispensary and Administration Site Information Presentation.
California Integrated Waste Management Board 1 Consideration of Revised Model Programs and Procedures for the Collection and Proper Disposal of Pharmaceutical.
Tracking Environmental Performance Presented by Rick Bauer, CEM, CEA, EMS-LA Vice President of Sustainability Services 880 Lennox Court Zionsville, IN.
FDA Regulatory and Compliance Symposium
BA 493 Article Review – Database tools help lawyers track clients Claire Brigham Kyle Alexander.
CONSEQUENCE ASSESSMENT. Consequence Assessment Definition: The analysis, evaluation, and interpretation of available information associated with an actual.
Legislative Analyst’s Office 0 Presentation to Annual Alternative Accountability Policy Forum November 16, 2015 San Diego, CA.
Evaluation of the Center for Irrigation Technology’s Agricultural Pumping Efficiency Program Presentation for the MAESTRO/CALMAC Evaluation Showcase.
California Integrated Waste Management Board 1 Consideration of Model Programs and Procedures for the Collection and Proper Disposal of Pharmaceutical.
The NWP as a National Infrastructure that Encourages Writing and the Teaching of Writing NWP Annual Meeting 2005 Inverness Research Associates.
PPSI Oregon Pilot Program Update Call 12/2/09 Oregon’s Paint Product Stewardship Law : 1 st in the Nation Abby Boudouris HHW Coordinator Oregon DEQ Alison.
DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?
Ethics & Engineering Design January 26, 2005 Dr. Nathan Ensmenger University of Pennsylvania
TMDL for Diazinon in Chollas Creek Watershed TMDL for Diazinon in Chollas Creek Watershed Linda Pardy (858) Jimmy.
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
Market Research Techniques Sustainable Small Acreage Farming and Ranching Cinda Williams, UI Extension 2005.
March 2016 Advancing Drugged Driving Data at the State Level: Synthesis of Barriers and Expert Panel Recommendations.
© 2016 Cengage Learning. All Rights Reserved. May not be scanned, copied or duplicated, or posted to a publicly accessible website, in whole or in part.
1 after legislation: evaluation for continued improvement in EPR programs 2015 NAHMMA Annual Conference September 16, 2015.
Local Governments Taking the Wheel on EPR Home-Generated Pharmaceutical Waste Collection Burke Lucy CalRecycle Sharps & Pharmaceutical Waste Specialist.
2.9 – Weighted Averages.
Marijuana Symposium Northern California
The importance of drug take-back programs: protecting our health and environment [TEMPLATE PRESENTATION] prepared by the product stewardship institute.
Safe Medicine Disposal for ME:
CHAPTER 17 Technical Sales Event
The importance of drug take-back programs: protecting our health and environment [TEMPLATE PRESENTATION] prepared by the product stewardship institute.
Experiential education Review
إستراتيجيات ونماذج التقويم
Timeline of Major Political and Economic Events
An Exploration of 3 Years of iTEAMS & STEM Education in
Prelisting Inspections
Annual Budget planning Participants Registration
Prelisting Inspections
Facility Partnerships Guideline Ministry of Education March 4, 2010
Revalidating using the CILIP Virtual Learning Environment
Increase Sales with Quantum BoatSM
WORKSHOP ON OPTIMAL PROCUREMENT OF AFFORDABLE AND QUALITY ASSURED LIFE-SAVING COMMODITIES FOR MATERNAL HEALTH KAMPALA, UGANDA - REGULATORY STATUS AND QUALITY.
Business Intent Presentation
Professional Military Divorce Lawyers in San Diego, California.
Presentation transcript:

Recommendations for Home-Generated Pharmaceutical Collection Programs in California

Disclosure The presenter DOES NOT have an interest in selling a technology, program, product, and/or service to CME/CE professionals.

Objectives Gain a broader context Assess program types Compare free-market results 3

International Context 4 4

5 5

6 6

7 7

8 8

9 9

10

International Context 11

International Context 12

International Context 13

International Context 14

International Context 15

International Context 16

International Context 17

International Context 18

International Context 19

International Context 20

International Context 21

International Context 22

International Context 23

International Context 24

International Context 25

International Context 26

International Context 27

International Context 28

International Context 29

International Context 30

International Context 31

International Context 32

International Context 33

International Context 34

International Context 35

International Context 36

International Context 37

International Context 38

International Context 39

International Context 40

International Context 41

International Context 42

International Context 43

International Context 44 France 80% of available

International Context 45 France 80% of available $0.12/lb

California Programs 46

47

48

49

50

51

52

53

54

55

56

57

Surveys 86% Response Rate 58

Programs begun before model guidelines (2008) Pre-existing Programs 59

Model Programs 5% 71% 33% 54% 37% 100% 60

Evaluation Criteria Safety Accessibility Cost Effectiveness Efficacy 61

Evaluation Criteria Safety Accessibility Cost Effectiveness Efficacy 62

% of Non-Model Pharmacies per Criterion Evaluation – safety (Pharmacies) Appropriate Access Track Responsibility 63

% of Non-Model Pharmacies per Criterion Evaluation – safety (Pharmacies) Appropriate Access Track Responsibility 64

% of Non-Model Law Enforcement per Criterion Evaluation – safety (law enforcement) Appropriate Access Track Responsibility 65

% of Non-Model HHWs per Criterion Evaluation – safety (HHW) Appropriate Access Track Responsibility 66

% of Non-Model Events per Criterion Appropriate Access Track Responsibility Evaluation – safety (Events) 67

% of Non-Model Mail-Back per Criterion Evaluation – safety (Mail-back) Appropriate Access Track Responsibility 68

Evaluation Criteria Safety Accessibility Cost Effectiveness Efficacy 69

Number of program sites (% of total) Evaluation – accessibility 70

Number of potential program sites (% actual sites out of total potential) Evaluation – accessibility 71

Average Number of Access Hours per Day Evaluation – accessibility 72

Evaluation Criteria Safety Accessibility Cost Effectiveness Efficacy 73

Average Cost per Pound Evaluation – cost effectiveness 74

Evaluation Criteria Safety Accessibility Cost Effectiveness Efficacy 75

Average Pounds Collected per Day of Operation Evaluation – efficacy 76

Total Pounds Collected by Program Type (July 1, 2009 to March 1, 2010 ) Evaluation – efficacy 77

Average Pounds Collected per Program Evaluation – efficacy 78

Free Market Results 79

San Francisco $110,000

Mailer Sale Sites Free Market Results 83

Mailer Sale Sites and Annual Collection Rates Free Market Results 84

Ontario, Canada Annual Collection Rates (tons) Free Market Results

Collection Rates Free Market Results

Questions? Burke Lucy (916)